[Diagnostic imaging in patients with multiple myeloma: appearance at magnetic resonance imaging]

Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.

Blood cancer journal·2015

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

Blood cancer journal·2012

Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model.

Blood cancer journal·2012

Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.

Oncology·2011

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.

Leukemia·2010

The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.

Leukemia·2006

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Complement-coagulation crosstalk in immunothrombosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

SWM dataset: A large-scale annotated benchmark for Sclerotinia sclerotiorum object detection in white mold management.

Data in brief·2026

Technical feasibility and mid-term outcomes of right mini-thoracotomy for double or triple heart valve surgery: a multicenter retrospective analysis.

Journal of thoracic disease·2026

Effect of daratumumab on patients with high-risk cytogenetic multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in immunology·2026

Out-of-hours presentation and 30-day myocardial infarction mortality in Mexico: a 2014-2023 retrospective study.

REC, interventional cardiology·2026

Evaluation of the mitral-aortic velocity time integral ratio for severity assessment in dogs with myxomatous mitral valve disease.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2026

Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples.

Clinical lymphoma, myeloma & leukemia·2026

Related Experiment Videos

[Diagnostic imaging in patients with multiple myeloma: appearance at magnetic resonance imaging]

Related Concept Videos

Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model.

Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.

The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Complement-coagulation crosstalk in immunothrombosis].

SWM dataset: A large-scale annotated benchmark for Sclerotinia sclerotiorum object detection in white mold management.

Technical feasibility and mid-term outcomes of right mini-thoracotomy for double or triple heart valve surgery: a multicenter retrospective analysis.

Effect of daratumumab on patients with high-risk cytogenetic multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Out-of-hours presentation and 30-day myocardial infarction mortality in Mexico: a 2014-2023 retrospective study.

Evaluation of the mitral-aortic velocity time integral ratio for severity assessment in dogs with myxomatous mitral valve disease.

Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples.

Related Experiment Videos

[Diagnostic imaging in patients with multiple myeloma: appearance at magnetic resonance imaging]

Related Concept Videos

Related Articles